San Francisco, California – Trebor Hardiman, a sickle cell patient from California, has filed a lawsuit against Pfizer’s wholly owned subsidiary Global Blood Therapeutics, Inc., claiming that the medication Oxbryta, developed, distributed, and sold by the company caused him significant injury. The lawsuit, filed on Hardiman’s behalf by the law firm Aylstock, Witkin, Kreis & … Continue reading AWKO Files Lawsuit on Behalf of Sickle Cell Patient Against Pfizer’s Subsidiary →